by Jean-Pierre Lindenmayer, MD Dr. Lindenmayer is Clinical Professor of the Department of Psychiatry at the NYU School of Medicine in New York, New York. Funding: No funding was provided
by Mark G. A. Opler, PhD, MPH; Christian Yavorsky, PhD; and David G Daniel, MD Dr. Opler is Adjunct Assistant Professor at NYU School of Medicine and Chief Research Officer
Innov Clin Neurosci. 2017;14(11–12)S1—S20. A Message From the Editor: Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased
by Sriram Ramaswamy, MD; David Driscoll, PhD; and Lynette M. Smith, PhD Dr. Ramaswamy is with the Department of Psychiatry, Creighton University School of Medicine, Omaha, Nebraska, and the VA
by Karim Yahia Jaffer; Tiffany Chang; Brigitte Vanle, PhD; Jonathan Dang, MD; Alexander J. Steiner, PsyD; Natalie Loera, BA; Marina Abdelmesseh, MD; Itai Danovitch, MD; and Waguih William IsHak, MD,
by David R. Spiegel, MD; Alexander Pattison, MD; Alexis Lyons, MD; Umer Ansari, MD; Aidan L. Mccroskey, MD; Eric Luehrs MD; Lauren Barr, BS; and Stephanie Le, MD All authors
by Katie T.B. Touma, PharmD, BCPP, BCPS; Allysa M. Zoucha, PharmD, BCPP; and Jonathan R. Scarff, MD Drs. Blissit and Zoucha are with William Jennings Bryan Dorn VA Medical Center,
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, in Hiroshima, Japan, and Dr. Nagamine is with
by Michael M. Messer, MD, and Irina V. Haller, PhD, MS Dr. Messer is with Behavioral Health Department, Essentia Health, Duluth, MN, and Dr. Haller is with Essentia Institute of
Innov Clin Neuro. 2017;14(1–2):12–13. Dear Editor: Hyperglycemia is more common in patients being treated with an antipsychotic than in the general population.[1] However, hypoglycemia is also a severe complication of
Innov Clin Neurosci. 2017;14(1–2)3–23. A MESSAGE FROM THE EDITOR Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased
by J. Gibson Pennington, MD, and Jeffrey Guina, MD From Wright-Patterson Air Force Base and Wright State University Boonshoft School of Medicine Department of Psychiatry, Dayton, Ohio Innov Clin Neurosci.
by Jonathan R. Scarff, MD Dr. Scarff is a staff psychiatrist at the Veterans Affairs Outpatient Clinic in Spartanburg, South Carolina, USA Innov Clin Neurosci. 2016;13(9–10):49–52 Funding: The author has
by Joanna P. MacEwan, PhD; Seth Seabury, PhD; Myrlene Sanon Aigbogun, MPH; Siddhesh Kamat, MS, MBA; Emma van Eijndhoven, MS, MA; Clement Francois, PhD; Crystal Henderson, PharmD, BCPP; and Leslie
by Jonathan R. Scarff, MD Dr. Scarff is with Veterans Affairs Outpatient Clinic, Spartanburg, South Carolina. Innov Clin Neurosci. 2016;13(7–8):26–29. Funding: No funding was received for the preparation of this
Innov Clin Neurosci. 2016;13(7–8):13–14. Dear Editor: Substance use disorders frequently coexist with and complicate the treatment of mood and anxiety disorders. Gabapentin is one of the most commonly prescribed off-label
by Masaru Nakamura, MD, PhD; Takahiko Nagamine, MD, PhD; Goro Sato, MD, PhD; and Kazue Besho, Phc Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima,
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
It’s Time for Combination Therapies in Multiple Sclerosis
by Jagannadha Avasarala, MD, PhD Dr. Avasarala is Associate Professor of Neurology, Division of Neurology, Department of Medicine, University of South Carolina School of Medicine, Greenville Health System, Greenville, South
Read More